Strs Ohio Eye Point Pharmaceuticals, Inc. Transaction History

Strs Ohio

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$8.16 - $22.89 $14,688 - $41,202	-1,800 Reduced 9.78%	16,600 $144,000
Q1 2024 May 13, 2024	SELL	$19.93 - $29.71 $97,657 - $145,579	-4,900 Reduced 21.03%	18,400 $380,000
Q4 2023 Jan 30, 2024	SELL	$5.71 - $24.13 $7,423 - $31,369	-1,300 Reduced 5.28%	23,300 $538,000
Q3 2023 Oct 26, 2023	BUY	$7.99 - $15.36 $196,554 - $377,856	24,600 New	24,600 $196,000

153

58.2M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $294M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.